Bio-Rad Laboratories BIO
NYSE BIO
$376.41 +12.15 (+3.34%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) EBIT Margin (QoQ) (2009 - 2026)

Bio-Rad Laboratories (BIO) EBIT Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 539.00
Mar 31, 2026 2,291.00
Dec 31, 2025 -2,715.00
Sep 30, 2025 -183.00
Jun 30, 2025 778.00
Mar 31, 2025 -469.00
Dec 31, 2024 -119.00
Sep 30, 2024 -597.00
Jun 30, 2024 859.00
Mar 31, 2024 -669.00
Dec 31, 2023 -40.00
Sep 30, 2023 123.00
Jun 30, 2023 401.00
Mar 31, 2023 -710.00
Dec 31, 2022 235.00
Sep 30, 2022 -388.00
Jun 30, 2022 -313.00
Mar 31, 2022 483.00
Dec 31, 2021 -490.00
Sep 30, 2021 356.00